Reeth Mark D - Insider Stock Trading - OpenInsider

CIK: 1399353 - Address: 8510 Colonnade Center Drive, Raleigh, NC 27615

7 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	6	-0	-2	3	1	21	36	10
S	%wins				83	83	33	33	17	25	46

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
5/3/12 17:35	5/1/12	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-49	48.91	0	-1	-3	34	D
7/6/11 16:33	7/5/11	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-297	40.32	24	-7	-17	36	D	311	3	-16	16	5	10	4	3	0	-5	-5	-27	17
5/17/11 16:26	5/16/11	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-135	39.84	33	-3	-7	47	D	328	9	-3	-4	17	9	7	2	0	-4	-11	-20	-6
6/15/10 16:04	6/14/10	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-155	36.24	33	-4	-10	39	D	417	270	60	19	-11	3	-2	6	0	-2	16	10	18	-4
5/19/10 11:34	5/17/10	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-126	37.38	33	-3	-7	44	D	393	257	73	31	-7	-7	-1	-5	2	3	4	13	16	11
11/24/09 12:54	11/23/09	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-80	23.64	19	-3	-7	49	D	117	200	158	84	3	17	16	7	0	0	8	23	59	87
5/5/08 16:53	5/1/08	SLXP	Salix Pharmaceuticals Ltd		Health	Drug	Pharmaceutical Preparations	Reeth Mark D	NC	O	GC,VP Co	S	-12	7.16	4	-2	-8	18	D	-48	-45	-38	8	12	12	11	0	-3	-3	4	9	24	51

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact